TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease

Abstract The translocase of outer mitochondrial membrane 40 (TOMM40) ‘523’ polymorphism has previously been associated with age of Alzheimer’s disease onset and cognitive functioning in non-pathological ageing, but has not been explored as a candidate risk marker for cognitive decline in Parkinson’s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Megan C. Bakeberg, Anastazja M. Gorecki, Abigail L. Pfaff, Madison E. Hoes, Sulev Kõks, P. Anthony Akkari, Frank L. Mastaglia, Ryan S. Anderton
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/30375ae8dea94afcbcdd8245b45abbe4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:30375ae8dea94afcbcdd8245b45abbe4
record_format dspace
spelling oai:doaj.org-article:30375ae8dea94afcbcdd8245b45abbe42021-12-02T18:34:20ZTOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease10.1038/s41531-021-00200-y2373-8057https://doaj.org/article/30375ae8dea94afcbcdd8245b45abbe42021-07-01T00:00:00Zhttps://doi.org/10.1038/s41531-021-00200-yhttps://doaj.org/toc/2373-8057Abstract The translocase of outer mitochondrial membrane 40 (TOMM40) ‘523’ polymorphism has previously been associated with age of Alzheimer’s disease onset and cognitive functioning in non-pathological ageing, but has not been explored as a candidate risk marker for cognitive decline in Parkinson’s disease (PD). Therefore, this longitudinal study investigated the role of the ‘523’ variant in cognitive decline in a patient cohort from the Parkinson’s Progression Markers Initiative. As such, a group of 368 people with PD were assessed annually for cognitive performance using multiple neuropsychological protocols, and were genotyped for the TOMM40 ‘523’ variant using whole-genome sequencing data. Covariate-adjusted generalised linear mixed models were utilised to examine the relationship between TOMM40 ‘523’ allele lengths and cognitive scores, while taking into account the APOE ε genotype. Cognitive scores declined over the 5-year study period and were lower in males than in females. When accounting for APOE ε4, the TOMM40 ‘523’ variant was not robustly associated with overall cognitive performance. However, in APOE ε3/ε3 carriers, who accounted for ~60% of the whole cohort, carriage of shorter ‘523’ alleles was associated with more severe cognitive decline in both sexes, while carriage of the longer alleles in females were associated with better preservation of global cognition and a number of cognitive sub-domains, and with a delay in progression to dementia. The findings indicate that when taken in conjunction with the APOE genotype, TOMM40 ‘523’ allele length is a significant independent determinant and marker for the trajectory of cognitive decline and risk of dementia in PD.Megan C. BakebergAnastazja M. GoreckiAbigail L. PfaffMadison E. HoesSulev KõksP. Anthony AkkariFrank L. MastagliaRyan S. AndertonNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 7, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurology. Diseases of the nervous system
RC346-429
Megan C. Bakeberg
Anastazja M. Gorecki
Abigail L. Pfaff
Madison E. Hoes
Sulev Kõks
P. Anthony Akkari
Frank L. Mastaglia
Ryan S. Anderton
TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
description Abstract The translocase of outer mitochondrial membrane 40 (TOMM40) ‘523’ polymorphism has previously been associated with age of Alzheimer’s disease onset and cognitive functioning in non-pathological ageing, but has not been explored as a candidate risk marker for cognitive decline in Parkinson’s disease (PD). Therefore, this longitudinal study investigated the role of the ‘523’ variant in cognitive decline in a patient cohort from the Parkinson’s Progression Markers Initiative. As such, a group of 368 people with PD were assessed annually for cognitive performance using multiple neuropsychological protocols, and were genotyped for the TOMM40 ‘523’ variant using whole-genome sequencing data. Covariate-adjusted generalised linear mixed models were utilised to examine the relationship between TOMM40 ‘523’ allele lengths and cognitive scores, while taking into account the APOE ε genotype. Cognitive scores declined over the 5-year study period and were lower in males than in females. When accounting for APOE ε4, the TOMM40 ‘523’ variant was not robustly associated with overall cognitive performance. However, in APOE ε3/ε3 carriers, who accounted for ~60% of the whole cohort, carriage of shorter ‘523’ alleles was associated with more severe cognitive decline in both sexes, while carriage of the longer alleles in females were associated with better preservation of global cognition and a number of cognitive sub-domains, and with a delay in progression to dementia. The findings indicate that when taken in conjunction with the APOE genotype, TOMM40 ‘523’ allele length is a significant independent determinant and marker for the trajectory of cognitive decline and risk of dementia in PD.
format article
author Megan C. Bakeberg
Anastazja M. Gorecki
Abigail L. Pfaff
Madison E. Hoes
Sulev Kõks
P. Anthony Akkari
Frank L. Mastaglia
Ryan S. Anderton
author_facet Megan C. Bakeberg
Anastazja M. Gorecki
Abigail L. Pfaff
Madison E. Hoes
Sulev Kõks
P. Anthony Akkari
Frank L. Mastaglia
Ryan S. Anderton
author_sort Megan C. Bakeberg
title TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
title_short TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
title_full TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
title_fullStr TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
title_full_unstemmed TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
title_sort tomm40 ‘523’ poly-t repeat length is a determinant of longitudinal cognitive decline in parkinson’s disease
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/30375ae8dea94afcbcdd8245b45abbe4
work_keys_str_mv AT megancbakeberg tomm40523polytrepeatlengthisadeterminantoflongitudinalcognitivedeclineinparkinsonsdisease
AT anastazjamgorecki tomm40523polytrepeatlengthisadeterminantoflongitudinalcognitivedeclineinparkinsonsdisease
AT abigaillpfaff tomm40523polytrepeatlengthisadeterminantoflongitudinalcognitivedeclineinparkinsonsdisease
AT madisonehoes tomm40523polytrepeatlengthisadeterminantoflongitudinalcognitivedeclineinparkinsonsdisease
AT sulevkoks tomm40523polytrepeatlengthisadeterminantoflongitudinalcognitivedeclineinparkinsonsdisease
AT panthonyakkari tomm40523polytrepeatlengthisadeterminantoflongitudinalcognitivedeclineinparkinsonsdisease
AT franklmastaglia tomm40523polytrepeatlengthisadeterminantoflongitudinalcognitivedeclineinparkinsonsdisease
AT ryansanderton tomm40523polytrepeatlengthisadeterminantoflongitudinalcognitivedeclineinparkinsonsdisease
_version_ 1718377851863957504